Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells

David M Peereboom; David M Peereboom; Tyler J Alban; Tyler J Alban; Matthew M Grabowski; Alvaro G Alvarado; Balint Otvos; Defne Bayik; Defne Bayik; Gustavo Roversi; Mary McGraw; Pengjing Huang; Alireza M Mohammadi; Harley I Kornblum; Tomas Radivoyevitch; Manmeet S Ahluwalia; Manmeet S Ahluwalia; Michael A Vogelbaum; Justin D Lathia

doi:10.1172/JCI.INSIGHT.130748

Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells

David M Peereboom
, David M Peereboom
, Tyler J Alban
, Tyler J Alban
, Matthew M Grabowski
, Alvaro G Alvarado
, Balint Otvos
, Defne Bayik
, Defne Bayik
, Gustavo Roversi
, Mary McGraw
, Pengjing Huang
, Alireza M Mohammadi
, Harley I Kornblum
, Tomas Radivoyevitch
, Manmeet S Ahluwalia
, Manmeet S Ahluwalia
, Michael A Vogelbaum
, Justin D Lathia

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	JCI insight
Volume	4
DOIs	https://doi.org/10.1172/JCI.INSIGHT.130748
State	Published - Nov 14 2019

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1172/JCI.INSIGHT.130748License: Unspecified

Cite this

Peereboom, D. M., Peereboom, D. M., Alban, T. J., Alban, T. J., Grabowski, M. M., Alvarado, A. G., Otvos, B., Bayik, D., Bayik, D., Roversi, G., McGraw, M., Huang, P., Mohammadi, A. M., Kornblum, H. I., Radivoyevitch, T., Ahluwalia, M. S., Ahluwalia, M. S., Vogelbaum, M. A., & Lathia, J. D. (2019). Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells. JCI insight, 4. https://doi.org/10.1172/JCI.INSIGHT.130748

Peereboom, DM, Peereboom, DM, Alban, TJ, Alban, TJ, Grabowski, MM, Alvarado, AG, Otvos, B, Bayik, D, Bayik, D, Roversi, G, McGraw, M, Huang, P, Mohammadi, AM, Kornblum, HI, Radivoyevitch, T, Ahluwalia, MS , Ahluwalia, MS, Vogelbaum, MA & Lathia, JD 2019, 'Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells', JCI insight, vol. 4. https://doi.org/10.1172/JCI.INSIGHT.130748

@article{762f8d13f6854423b4de6c639ab6ec9a,

title = "Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells",

author = "Peereboom, \{David M\} and Peereboom, \{David M\} and Alban, \{Tyler J\} and Alban, \{Tyler J\} and Grabowski, \{Matthew M\} and Alvarado, \{Alvaro G\} and Balint Otvos and Defne Bayik and Defne Bayik and Gustavo Roversi and Mary McGraw and Pengjing Huang and Mohammadi, \{Alireza M\} and Kornblum, \{Harley I\} and Tomas Radivoyevitch and Ahluwalia, \{Manmeet S\} and Ahluwalia, \{Manmeet S\} and Vogelbaum, \{Michael A\} and Lathia, \{Justin D\}",

note = "BACKGROUND Myeloid-derived suppressor cells (MDSCs) are elevated in the circulation of patients with glioblastoma (GBM), present in tumor tissue, and associated with poor prognosis.",

year = "2019",

month = nov,

day = "14",

doi = "10.1172/JCI.INSIGHT.130748",

language = "American English",

volume = "4",

journal = "JCI insight",

}

TY - JOUR

T1 - Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells

AU - Peereboom, David M

AU - Alban, Tyler J

AU - Grabowski, Matthew M

AU - Alvarado, Alvaro G

AU - Otvos, Balint

AU - Bayik, Defne

AU - Roversi, Gustavo

AU - McGraw, Mary

AU - Huang, Pengjing

AU - Mohammadi, Alireza M

AU - Kornblum, Harley I

AU - Radivoyevitch, Tomas

AU - Ahluwalia, Manmeet S

AU - Vogelbaum, Michael A

AU - Lathia, Justin D

N1 - BACKGROUND Myeloid-derived suppressor cells (MDSCs) are elevated in the circulation of patients with glioblastoma (GBM), present in tumor tissue, and associated with poor prognosis.

PY - 2019/11/14

Y1 - 2019/11/14

UR - https://insight.jci.org/articles/view/130748/pdf

U2 - 10.1172/JCI.INSIGHT.130748

DO - 10.1172/JCI.INSIGHT.130748

M3 - Article

VL - 4

JO - JCI insight

JF - JCI insight

ER -

Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells

Disciplines

Access to Document

Other files and links

Cite this